======= TAF1A ======= == Gene Information == * **Official Symbol**: TAF1A * **Official Name**: TATA-box binding protein associated factor, RNA polymerase I subunit A * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9015|9015]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q15573|Q15573]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TAF1A&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TAF1A|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604903|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the transcription factor SL1/TIF-IB complex, which is involved in the assembly of the PIC (pre- initiation complex) during RNA polymerase I-dependent transcription. The rate of PIC formation probably is primarily dependent on the rate of association of SL1/TIF-IB with the rDNA promoter. SL1/TIF-IB is involved in stabilization of nucleolar transcription factor 1/UBTF on rDNA. Formation of SL1/TIF-IB excludes the association of TBP with TFIID subunits. {ECO:0000269|PubMed:15970593, ECO:0000269|PubMed:7801123}. No Pfam Domain information is available for this gene. |RNA polymerase I transcription factor complex| |transcription elongation from RNA polymerase I promoter| |termination of RNA polymerase I transcription| |transcription initiation from RNA polymerase I promoter| |transcription by RNA polymerase I| |positive regulation of gene expression, epigenetic| |DNA-templated transcription, termination| |DNA-templated transcription, elongation| |microtubule cytoskeleton| |DNA-templated transcription, initiation| |regulation of gene expression, epigenetic| |transcription by RNA polymerase II| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |DNA binding| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |positive regulation of gene expression| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp314|Dimethyloxaloylglycine 11μM R07 exp314]]|-2.01| |[[:results:exp10|CCCP 0.1μM R00 exp10]]|-2| |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|-1.93| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|-1.91| |[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|-1.89| |[[:results:exp146|Quinacrine 2.5μM R03 exp146]]|-1.84| |[[:results:exp317|Geldanamycin 0.015 to 0.05μM on day4 R07 exp317]]|-1.83| |[[:results:exp308|Rapamycin 2μM plus FK-506 5μM R07 exp308]]|-1.77| |[[:results:exp438|NN-Diethyl-meta-toluamide 500μM R08 exp438]]|-1.72| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|-1.71| ^Gene^Correlation^ |[[:human genes:h:hars|HARS]]|0.505| |[[:human genes:t:thg1l|THG1L]]|0.484| |[[:human genes:g:gemin8|GEMIN8]]|0.484| |[[:human genes:d:ddx20|DDX20]]|0.48| |[[:human genes:s:srp14|SRP14]]|0.472| |[[:human genes:p:pmm2|PMM2]]|0.467| |[[:human genes:a:alg1|ALG1]]|0.45| |[[:human genes:g:gemin7|GEMIN7]]|0.446| |[[:human genes:g:gemin6|GEMIN6]]|0.443| |[[:human genes:g:gtf3c6|GTF3C6]]|0.441| |[[:human genes:r:rpp21|RPP21]]|0.433| |[[:human genes:e:exoc4|EXOC4]]|0.432| |[[:human genes:e:eif3f|EIF3F]]|0.431| |[[:human genes:r:rptor|RPTOR]]|0.431| |[[:human genes:l:lsm10|LSM10]]|0.427| |[[:human genes:u:uhrf1|UHRF1]]|0.425| |[[:human genes:t:ten1|TEN1]]|0.424| |[[:human genes:a:adsl|ADSL]]|0.419| |[[:human genes:u:utp23|UTP23]]|0.419| |[[:human genes:d:dhrsx|DHRSX]]|0.417| |[[:human genes:c:cep57|CEP57]]|0.417| |[[:human genes:t:txnl4b|TXNL4B]]|0.417| |[[:human genes:d:dpagt1|DPAGT1]]|0.417| |[[:human genes:u:uxt|UXT]]|0.417| |[[:human genes:n:nsmce1|NSMCE1]]|0.415| |[[:human genes:s:snapc5|SNAPC5]]|0.414| |[[:human genes:r:rtcb|RTCB]]|0.413| |[[:human genes:r:rnmt|RNMT]]|0.413| |[[:human genes:z:zrsr2|ZRSR2]]|0.41| |[[:human genes:r:rpia|RPIA]]|0.409| |[[:human genes:v:vezt|VEZT]]|0.408| |[[:human genes:p:ppp4c|PPP4C]]|0.408| |[[:human genes:p:ppcs|PPCS]]|0.407| |[[:human genes:p:ppa2|PPA2]]|0.404| |[[:human genes:t:triap1|TRIAP1]]|0.404| |[[:human genes:g:gmppb|GMPPB]]|0.403| |[[:human genes:a:atxn10|ATXN10]]|0.402| |[[:human genes:d:ddx39a|DDX39A]]|0.402| |[[:human genes:g:gtf3c3|GTF3C3]]|0.402| |[[:human genes:p:pggt1b|PGGT1B]]|0.402| |[[:human genes:p:ppp6c|PPP6C]]|0.401| |[[:human genes:g:gemin4|GEMIN4]]|0.4| Global Fraction of Cell Lines Where Essential: 1/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|1/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3150 * **Expression level (log2 read counts)**: 4.45 {{:chemogenomics:nalm6 dist.png?nolink |}}